BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 9441554)

  • 21. [The use of antithyroid drugs should be reduced as much as possible in the first trimester].
    Andersen SL; Laurberg P
    Ugeskr Laeger; 2014 Sep; 176(39):. PubMed ID: 25294327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Propylthiouracil versus methimazole in treatment of Graves' disease during pregnancy.
    Chattaway JM; Klepser TB
    Ann Pharmacother; 2007 Jun; 41(6):1018-22. PubMed ID: 17504839
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis.
    Mandel SJ; Brent GA; Larsen PR
    Thyroid; 1994; 4(1):129-33. PubMed ID: 7519913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The safety of methimazole and propylthiouracil in pregnancy: a systematic review.
    Hackmon R; Blichowski M; Koren G
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1077-1086. PubMed ID: 23231846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety of antithyroid drugs in pregnancy: update and therapy implications.
    Francis T; Francis N; Lazarus JH; Okosieme OE
    Expert Opin Drug Saf; 2020 May; 19(5):565-576. PubMed ID: 32223355
    [No Abstract]   [Full Text] [Related]  

  • 26. Thyroid medications during pregnancy.
    Bach-Huynh TG; Jonklaas J
    Ther Drug Monit; 2006 Jun; 28(3):431-41. PubMed ID: 16778730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of thyroid disease in pregnancy.
    Wang KW; Sum CF
    Singapore Med J; 1989 Oct; 30(5):476-8. PubMed ID: 2694376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study.
    Chen CH; Xirasagar S; Lin CC; Wang LH; Kou YR; Lin HC
    BJOG; 2011 Oct; 118(11):1365-73. PubMed ID: 21624036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status.
    Momotani N; Noh J; Oyanagi H; Ishikawa N; Ito K
    N Engl J Med; 1986 Jul; 315(1):24-8. PubMed ID: 2423874
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Current problems in the treatment of Graves' disease in pregnancy and in lactation].
    Momotani N
    Nihon Rinsho; 2006 Dec; 64(12):2297-302. PubMed ID: 17154095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study.
    Rosenfeld H; Ornoy A; Shechtman S; Diav-Citrin O
    Br J Clin Pharmacol; 2009 Oct; 68(4):609-17. PubMed ID: 19843064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjustment of L-T4 substitutive therapy in pregnant women with subclinical, overt or post-ablative hypothyroidism.
    Verga U; Bergamaschi S; Cortelazzi D; Ronzoni S; Marconi AM; Beck-Peccoz P
    Clin Endocrinol (Oxf); 2009 May; 70(5):798-802. PubMed ID: 18771569
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid disease in pregnancy and childhood.
    Lazarus JH
    Minerva Endocrinol; 2005 Jun; 30(2):71-87. PubMed ID: 15988403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drugs for thyroid disorders.
    Treat Guidel Med Lett; 2009 Aug; 7(84):57-64; quiz 2p following 64. PubMed ID: 19636287
    [No Abstract]   [Full Text] [Related]  

  • 35. Premature twins of a mother with Graves' disease with discordant thyroid function: a case report.
    O'Connor MJ; Paget-Brown AO; Clarke WL
    J Perinatol; 2007 Jun; 27(6):388-9. PubMed ID: 17522687
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of congenital anomalies associated with antithyroid treatment during pregnancy: a meta-analysis.
    Li X; Liu GY; Ma JL; Zhou L
    Clinics (Sao Paulo); 2015 Jun; 70(6):453-9. PubMed ID: 26106966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism.
    Tsai WC; Pei D; Wang TF; Wu DA; Li JC; Wei CL; Lee CH; Chen SP; Kuo SW
    Clin Endocrinol (Oxf); 2005 May; 62(5):521-4. PubMed ID: 15853819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of medications and hormones used in the treatment of pediatric thyroid disorders.
    Beck-Peccoz P; Persani L; LaFranchi S
    Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():124-33. PubMed ID: 16456491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pregnancy and the thyroid gland].
    Lieutaud H
    Ann Med Interne (Paris); 1999 Sep; 150(5):397-407. PubMed ID: 10544750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obstetric implications of current Australian product information for thyroid-related medications.
    Stockigt JR
    Aust N Z J Obstet Gynaecol; 2009 Feb; 49(1):64-6. PubMed ID: 19281582
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.